138 related articles for article (PubMed ID: 19336723)
1. New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs.
Dubois RN
Cancer Prev Res (Phila); 2009 Apr; 2(4):285-7. PubMed ID: 19336723
[No Abstract] [Full Text] [Related]
2. Does celecoxib use increase the risk of cardiovascular events?
Oviedo JA; Schroy PC
Gastroenterology; 2005 Oct; 129(4):1348-50. PubMed ID: 16230088
[No Abstract] [Full Text] [Related]
3. Letter by Cen regarding article, "Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas".
Cen YY
Circulation; 2007 Mar; 115(12):e348; author reply e349. PubMed ID: 17389275
[No Abstract] [Full Text] [Related]
4. Celecoxib and CVS risk--lessons from the APC and PreSAP studies.
Armstrong DJ
Rheumatology (Oxford); 2007 Apr; 46(4):561-2. PubMed ID: 17132690
[No Abstract] [Full Text] [Related]
5. Risks and benefits of celecoxib to prevent recurrent adenomas.
Psaty BM; Potter JD
N Engl J Med; 2006 Aug; 355(9):950-2. PubMed ID: 16943408
[No Abstract] [Full Text] [Related]
6. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.
Solomon SD; McMurray JJ; Pfeffer MA; Wittes J; Fowler R; Finn P; Anderson WF; Zauber A; Hawk E; Bertagnolli M;
N Engl J Med; 2005 Mar; 352(11):1071-80. PubMed ID: 15713944
[TBL] [Abstract][Full Text] [Related]
7. Arthritis medicines and cardiovascular events--"house of coxibs".
Topol EJ
JAMA; 2005 Jan; 293(3):366-8. PubMed ID: 15623849
[No Abstract] [Full Text] [Related]
8. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas.
Solomon SD; Pfeffer MA; McMurray JJ; Fowler R; Finn P; Levin B; Eagle C; Hawk E; Lechuga M; Zauber AG; Bertagnolli MM; Arber N; Wittes J;
Circulation; 2006 Sep; 114(10):1028-35. PubMed ID: 16943394
[TBL] [Abstract][Full Text] [Related]
9. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
[No Abstract] [Full Text] [Related]
10. Risks and benefits of celecoxib to prevent colorectal adenomas.
Andersohn F; Suissa S; Garbe E
N Engl J Med; 2006 Nov; 355(22):2371; author reply 2371-3. PubMed ID: 17135594
[No Abstract] [Full Text] [Related]
11. Coxibs and cardiovascular risk.
Allen MJ; McLean-Veysey P; Fleming I
CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
[No Abstract] [Full Text] [Related]
12. Coxib toxicity: a likely class effect.
Prescrire Int; 2005 Feb; 14(75):22. PubMed ID: 15751177
[TBL] [Abstract][Full Text] [Related]
13. Celebrex: new ad, with questionable claims.
Consum Rep; 2007 Aug; 72(8):52-3. PubMed ID: 17644835
[No Abstract] [Full Text] [Related]
14. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib shown effective in preventing colon polyps.
Nelson NJ
J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118
[No Abstract] [Full Text] [Related]
16. The adenoma prevention with celecoxib and prevention of colorectal sporadic adenomatous polyps trials: stepping stones to progress.
Hawk E; Viner JL
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):185-7. PubMed ID: 17301246
[No Abstract] [Full Text] [Related]
17. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?
Messerli FH; Sichrovsky T
Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380
[No Abstract] [Full Text] [Related]
18. Cyclooxygenase-2 inhibitors and cardiovascular risk.
Smith ER
Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
[No Abstract] [Full Text] [Related]
19. [Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall].
Meyer CH
Klin Monbl Augenheilkd; 2005 Jan; 222(1):62-3. PubMed ID: 15678404
[No Abstract] [Full Text] [Related]
20. Rescuing COX-2 inhibitors from the waste bin.
Albini A; Noonan DM
J Natl Cancer Inst; 2005 Jun; 97(11):859-60. PubMed ID: 15928309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
